AzTrials
AzTrials

Body RepresentationReCONNAISSANCENCT06042075

Representation of Congenital Birthmarks

An observational study of Body Representation and Congenital Skin Disorder, run by University Hospital, Angers at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This descriptive cross-sectional single center study will be conducted at Angers Maternity Unit. It pertains to the ways in which healthcare professionals represent congenital birthmarks found in newborns. Read more about this study

Who is it for?
Any age
What is being tested?
Questionnaire on congenital birthmarks
How many people
140 participants
Where
1 siteFrance
Study dates
Oct 2023to Jun 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: All health professionnals working at Angers Maternity Unit: midwives, nursing auxiliaries, childcare assistants, gynecologists, residents, pediatricians

Who may be able to join

  • All health professionnals working at Angers Maternity Unit:
  • Midwives
  • Nursing auxiliaries
  • Childcare assistants
  • Gynecologists
  • Residents
  • Pediatricians

Who cannot join

  • Refusal to participate
  • Non-health professionals working at Angers Maternity Unit (hospital cleaners, hospital food workers)
  • Students (trainee pediatricians, trainee gynecologists, trainee midwives)

Trial locations and contacts

1 site in 1 country.

France1 site
  • Department of Dermatology, University Hospital of Angers

    Angers, Pays de Loire, 49933

    Ludovic Martin, MD, PhD, 02.41.35.34.19 ext. +33, LuMartin@chu-angers.fr

    BERTHELOT Brieuc, Resident

Other trials in France

About this study

Official title: Representation of Congenital Birthmarks in Newborns by Angers Maternity Unit Health Professionals

This descriptive cross-sectional single center study will be conducted at Angers Maternity Unit.

It pertains to the ways in which healthcare professionals represent congenital birthmarks found in newborns.

Read more

It is our assumption that health professionals may have a tendency to engage in inappropriate behavior when dealing with congenital birthmarks due to lack of knowledge. We make the presumption that insufficient knowledge causes difficulties in managing these birthmarks.

Data as to representation of birthmarks in newborns by health professionals will be collected using a semi-quantitative questionnaire.

This study constitutes preliminary research work, with a view to creating a professional development plan if necessary.

Read the detailed description

This descriptive cross-sectional observational study will take place at a single center: Angers Hospital Maternity Unit.

Our aim is to assess how healthcare professionals represent congenital birthmarks in newborn infants.

We intend to use an optional anonymous questionnaire that will be placed strategically in Angers Maternity Unit workspaces . Each health professional from Angers Maternity Unit will be asked to complete this questionnaire.

In this five-minute questionnaire, they will be asked questions regarding their representation of congenital birthmarks, their feelings and their knowledge.

We make the hypothesis that some health professionals lack knowledge and are uncomfortable with managing these birthmarks and providing explanations to the parents of newborn infants. We also show them some examples of birthmarks, prompting them to express any feelings they may have.

This questionnaire was co-written by Pauline VABRES, a psychologist with experience in the field of self-representation.

The questionnaire will remain accessible for 45 days, ensuring that every Maternity Unit health professional has the opportunity to participate (approximately 140 people, excluding non-health professionals working in the Maternity Unit and students).

On completion of the questionnaire, the healthcare professionals will seal their answers in envelopes to guarantee anonymity.

At the end of the 45-day period, the answers will be collected and analyzed.

If required, the second phase of this work will focus on developing educational interventions for health professionals to enhance their knowledge of congenital birthmarks. We also hope to improve management of these lesions and enhance the quality of the explanations provided to parents of newborns.

Previous studies have already addressed the feelings of parents confronted with congenital birthmarks. To our knowledge, this is the first study of its kind to evaluate the perspective of health professionals

Being tested
Questionnaire on congenital birthmarks
Keywords
Newborns, Health Professionals, Maternity Unit, Congenital Birthmarks
Medical subject headings
Skin Abnormalities

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Questionnaire on congenital birthmarksOther

    Questions will be put to health professionals on representation using a semi-quantitative questionnaire.

Study groups in NCT06042075
Study groupRoleWhat they receive
Health professionalsHealth professionals working at Angers Maternity Unit include gynecologists, pediatricians, residents (gynecology and pediatric residents), childcare assistants, nursing auxiliaries and midwives.
Receives: Other: Questionnaire on congenital birthmarks

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assessment of the ways in which health professionals from Angers Maternity Unit represent congenital birthmarks found in newborns

    Representation by health professionals will be assessed using a semi-quantitative questionnaire

    Measured: 45 days

Secondary outcomes (1)
  1. Assessment of the proportion of health professionals wishing to improve their knowledge of congenital birthmarks

    The question will be put to health professionals using a questionnaire

    Measured: 45 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Sep 2023
  2. Study startOct 2023 (estimated)
  3. Primary completionNov 2023 (estimated)
  4. Study completionJun 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
140 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06042075
Sponsor's protocol ID
2023-0-100
Acronym
ReCONNAISSANCE
Status last verified
Sep 2023
First submitted
11 Sep 2023
Last updated
18 Sep 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Kelly KA, Balogh EA, Kaplan SG, Feldman SR. Skin Disease in Children: Effects on Quality of Life, Stigmatization, Bullying, and Suicide Risk in Pediatric Acne, Atopic Dermatitis, and Psoriasis Patients. Children (Basel). 2021 Nov 16;8(11):1057. doi: 10.3390/children8111057.

    PubMed 34828770
  • Vivar KL, Kruse L. The impact of pediatric skin disease on self-esteem. Int J Womens Dermatol. 2017 Dec 12;4(1):27-31. doi: 10.1016/j.ijwd.2017.11.002. eCollection 2018 Mar.

    PubMed 29872673

Questions about this trial

What is this clinical trial studying?

An observational study of Body Representation and Congenital Skin Disorder, run by University Hospital, Angers at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ludovic Martin, MD PhD (02.41.35.34.19 ext. +33, LuMartin@chu-angers.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assessment of the ways in which health professionals from Angers Maternity Unit represent congenital birthmarks found in newborns (time frame: 45 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06042075, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in